BioSpace News Archive

Emerged Inc., today announced its strategic partnership with Round One Capital. Round One Capital has invested an undisclosed amount in the seed round, and Jay Love, co-founder of Round One Capital - who previously held CEO titles at eTapestry and Bloomerang - will sit on Emerged’s Board of Directors

Aimmune Therapeutics, today announced the launch of PACT-CP, a Patient-Centric Chronic Pancreatitis Registry study to better understand the unmet needs and therapeutic burden on patients with EPI due to chronic pancreatitis (CP).

According to the report, the global learning disabilities treatment market was valued at ~US$ 3 Bn in 2018 and is projected to expand at a considerable CAGR during the forecast period.

The National Women’s Health Network states that the hysterectomy is the second most frequently performed surgical procedure in the U.S. The data published by the Centers for Disease Control and Prevention states that from 2006 to 2010, 11.7% of women of the age group from 40 to 44 has a hysterectomy.

The growth of the global d-dimer testing market is ascribed to its high demand across the globe. Shortage of radiological interventions, cost effectiveness, and high accuracy is expected to bolster demand for d-dimer tests over the timeframe of analysis, from 2019 to 2029.

Fact MR: The global lab automation market is forecast to surpass the valuation of US$ 1 trillion by end of 2031.

Qualtrics, the world’s No. 1 Experience Management provider and creator of the XM category, announced that Ardent Health Services, one of the industry’s most innovative healthcare systems with 30 hospitals and 25,000 employees nationwide, has chosen Qualtrics to transform and elevate the experiences of both patients and health care workers.

BD, a leading global medical technology company, announced that it has received pandemic orders for needles and syringes totaling 2 billion injection devices to support global COVID-19 vaccination efforts.

AzurRx BioPharma, Inc., a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases, announced that James Sapirstein, Chief Executive Officer of AzurRx, will present at the 2021 BIO Digital.

CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it has acquired Transplant Hero LLC, a New York-based provider of a mobile application supporting the needs of transplant patients.